FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

764296002: Prolonged-release subcutaneous implant (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3647392011 Prolonged-release subcutaneous implant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647393018 Prolonged-release subcutaneous implant (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release subcutaneous implant Has dose form administration method (attribute) A method of administration of a dose form by being placed into a body cavity. false Inferred relationship Some
Prolonged-release subcutaneous implant Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release subcutaneous implant Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration into the subcutaneous tissue. true Inferred relationship Some
Prolonged-release subcutaneous implant Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Prolonged-release subcutaneous implant Has basic dose form (attribute) Implant true Inferred relationship Some
Prolonged-release subcutaneous implant Is a Subcutaneous dose form true Inferred relationship Some
Prolonged-release subcutaneous implant Has dose form administration method (attribute) A method of administration of a dose form by being placed within a tissue of the body. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Estradiol 100 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Etonogestrel 68mg subdermal implant Has manufactured dose form False Prolonged-release subcutaneous implant Inferred relationship Some
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Testosterone 100 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Testosterone 200 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Levonorgestrel 75 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Has manufactured dose form True Prolonged-release subcutaneous implant Inferred relationship Some

This concept is not in any reference sets

Back to Start